These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 25151983)

  • 1. Stimuli-responsive nanomaterials for therapeutic protein delivery.
    Lu Y; Sun W; Gu Z
    J Control Release; 2014 Nov; 194():1-19. PubMed ID: 25151983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in intelligent-responsive nanocarriers for cancer therapy.
    Tian M; Xin X; Wu R; Guan W; Zhou W
    Pharmacol Res; 2022 Apr; 178():106184. PubMed ID: 35301111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptive Polymeric Assemblies for Applications in Biomimicry and Nanomedicine.
    Altay Y; Cao S; Che H; Abdelmohsen LKEA; van Hest JCM
    Biomacromolecules; 2019 Nov; 20(11):4053-4064. PubMed ID: 31642319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Nanotechnology in Delivery of Protein and Peptide Drugs.
    Patil S; Vhora I; Amrutiya J; Lalani R; Misra A
    Curr Pharm Des; 2015; 21(29):4155-73. PubMed ID: 26323432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translating Nanomedicine to Comparative Oncology-the Case for Combining Zinc Oxide Nanomaterials with Nucleic Acid Therapeutic and Protein Delivery for Treating Metastatic Cancer.
    DeLong RK; Cheng YH; Pearson P; Lin Z; Coffee C; Mathew EN; Hoffman A; Wouda RM; Higginbotham ML
    J Pharmacol Exp Ther; 2019 Sep; 370(3):671-681. PubMed ID: 31040175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanocarriers for pulmonary administration of peptides and therapeutic proteins.
    Andrade F; Videira M; Ferreira D; Sarmento B
    Nanomedicine (Lond); 2011 Jan; 6(1):123-41. PubMed ID: 21182424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomedicine for respiratory diseases.
    Swai H; Semete B; Kalombo L; Chelule P; Kisich K; Sievers B
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(3):255-63. PubMed ID: 20049795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial nanomedicine.
    Yacoby I; Benhar I
    Nanomedicine (Lond); 2008 Jun; 3(3):329-41. PubMed ID: 18510428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in Self-assembling Peptide-based Nanomaterials for Biomedical Applications.
    Yu CY; Huang W; Li ZP; Lei XY; He DX; Sun L
    Curr Top Med Chem; 2016; 16(3):281-90. PubMed ID: 26126914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimuli-Responsive Polymeric Systems for Controlled Protein and Peptide Delivery: Future Implications for Ocular Delivery.
    Mahlumba P; Choonara YE; Kumar P; du Toit LC; Pillay V
    Molecules; 2016 Jul; 21(8):. PubMed ID: 27483234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classification of stimuli-responsive polymers as anticancer drug delivery systems.
    Taghizadeh B; Taranejoo S; Monemian SA; Salehi Moghaddam Z; Daliri K; Derakhshankhah H; Derakhshani Z
    Drug Deliv; 2015 Feb; 22(2):145-55. PubMed ID: 24547737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomaterials multifunctional behavior for enlightened cancer therapeutics.
    Raju GSR; Dariya B; Mungamuri SK; Chalikonda G; Kang SM; Khan IN; Sushma PS; Nagaraju GP; Pavitra E; Han YK
    Semin Cancer Biol; 2021 Feb; 69():178-189. PubMed ID: 31419527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-assembling Peptides in Current Nanomedicine: Versatile Nanomaterials for Drug Delivery.
    Peng F; Zhang W; Qiu F
    Curr Med Chem; 2020; 27(29):4855-4881. PubMed ID: 31309877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Internally Responsive Nanomaterials for Activatable Multimodal Imaging of Cancer.
    Rosenkrans ZT; Ferreira CA; Ni D; Cai W
    Adv Healthc Mater; 2021 Mar; 10(5):e2000690. PubMed ID: 32691969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimuli-responsive polymeric micelles for drug delivery and cancer therapy.
    Zhou Q; Zhang L; Yang T; Wu H
    Int J Nanomedicine; 2018; 13():2921-2942. PubMed ID: 29849457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous stimuli-responsive drug delivery nanoplatforms for kidney disease therapy.
    Fang H; Xu S; Wang Y; Yang H; Su D
    Colloids Surf B Biointerfaces; 2023 Dec; 232():113598. PubMed ID: 37866237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging strategies in developing multifunctional nanomaterials for cancer nanotheranostics.
    Ang MJY; Chan SY; Goh YY; Luo Z; Lau JW; Liu X
    Adv Drug Deliv Rev; 2021 Nov; 178():113907. PubMed ID: 34371084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme-responsive nanomaterials for controlled drug delivery.
    Hu Q; Katti PS; Gu Z
    Nanoscale; 2014 Nov; 6(21):12273-86. PubMed ID: 25251024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanostructures for pH-sensitive Drug Delivery and Magnetic Resonance Contrast Enhancement Systems.
    Sun X; Zhang G; Wu Z
    Curr Med Chem; 2018; 25(25):3036-3057. PubMed ID: 28393692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimuli-responsive polymeric nanoparticles for nanomedicine.
    Crucho CI
    ChemMedChem; 2015 Jan; 10(1):24-38. PubMed ID: 25319803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.